On August 1, August 1, 丨ST Haiyue (600387.SH) announced that the company held the 27th meeting of the 9th board of directors on July 31, 2023 to review and unanimously pass the “Proposal on Taking the Opportunity to Reduce the Remaining Shares of Zhejiang Huakang Pharmaceutical Co., Ltd.”, authorizing the chairman to take the opportunity to reduce all shares of Huakang Co., Ltd. within 6 months from the date of approval by the board of directors. Up to now, the company holds 478,500 shares of Huakang Co., Ltd., accounting for 0.21% of its total share capital.